Agreements

* On October 16, 2013, Diaxonhit has announced that InGen, its commercialization affiliate, has signed a partnership agreement with Tosoh Europe for the marketing of immunoassay instruments in France and its overseas territories. Diaxonhit is already active in the field of immunoassays, which represented approximately 12% of its sales as at June 30, 2013. With this agreement, the Group will be able to offer to clinical laboratories two high-performance automated systems manufactured by Tosoh, the AIA360 and AIA900. These high-speed instruments with 36 and 90 tests/hour, respectively, offer a choice of 44 different parameters with a recognized operational reliability. The ability of these devices to facilitate quality accreditation is also a major asset.